Fahim Abbasi,Cindy Lamendola,Chelsea S. Harris,Vander Harris,Ming‐Shian Tsai,Pragya Tripathi,Fakhar Abbas,Gerald M. Reaven,Peter D. Reaven,M Snyder,Sun H. Kim,Joshua W. Knowles
Statin treatment reduces the risk of atherosclerotic cardiovascular disease but is associated with a modest increased risk of type 2 diabetes, especially in those with insulin resistance or prediabetes. Our objective was to determine the physiological mechanism for the increased type 2 diabetes risk.